The U.S. is the global leader in the trade of in-vitro diagnostic substances, accounting for a 23% share (based on USD) of the world’s exports. It was followed by Germany (19%), the UK (8%), and the Netherlands (8%).
The U.S. exported 6,437 million USD in 2015, which was 2% above the previous year’s value. Outside of the barely noticeable decline of 2009, U.S. exports of in-vitro diagnostic substances showed steady growth from 2007 to 2015. There was an average annual increase of +4.4% throughout the analysed period. As U.S. companies consistently improved their positions on overseas markets, domestic manufacturers enjoyed a new growth driver.
Germany (19%), and, distantly, Canada (9%), China (8%), and Japan (7%) were the main destinations of U.S. in-vitro diagnostic substance exports in 2015. The shares exported to Germany and Canada remained relatively stable from 2007 to 2015. Meanwhile, China’s share increased by +6 percentage points, and the share sent to Japan illustrated negative dynamics (-5 percentage points).
From 2007 to 2015, the U.S. was a net exporter of in-vitro diagnostic substances. However, imports grew generally in line with exports on average over the period under review. Net U.S. exports of in-vitro diagnostic substances increased gradually over the period under review. In 2015, this industry ran a significant trade surplus of 2,958 million USD.
Follow the link below to review a free sample or to buy the report: http://www.indexbox.co.uk/store/us-in-vitro-diagnostic-substances-market-analysis-and-forecast-to-2020/
“U.S. In-Vitro Diagnostic Substances Market. Analysis And Forecast to 2020” provides an in-depth analysis of the U.S. in-vitro diagnostic substance market. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. In addition, the report contains insightful information about the industry, including industry life cycle, business locations, productivity, employment and many other crucial aspects. The Company Profiles section contains relevant data on the major players in the industry.
Countries coverage: the U.S.
- Market size;
- Domestic production, value of shipments;
- Key market players and their profiles;
- Exports, imports and trade balance;
- Import and export prices;
- Forecast of the market dynamics in the medium term;
- Key industry statistics;
- Life cycle of the industry;
- Number of establishments and their locations;
- Employment data;
- Industry productivity.
Product coverage: In-vitro diagnostic substances
Companies mentioned: Abbott Diabetes Care, Orasure Technologies, Amag Pharmaceuticals, Streck, Diasorin Inc., Diadexus, Rapid Pathogen Screening, Maine Biotechnology Services, Saladax Biomedical, Corgenix Medical Corporation, George King Bio-Medical, Princeton Biomeditech Corp, Banyan Biomarkers, Anatech, Dxna LLC, CD Diagnostics, Akers Biosciences, Helica Biosystems, Green Mountain Antibodies, Biospacific, Innominata, Phase 2 Discovery, Immuno Concepts, Hepatochem, Lifecare Medical International, Horizon Diagnostic, Immucor Gti Diagnostics, Werfen USA, Ivd Intermediate Holdings B Inc., Opko Diagnostics, Horizon Diagnostic Inc, Immucor Gti Diagnostics, Werfen USA, Ivd Intermediate Holdings B Inc., Opko Diagnostics.
Why buy “U.S. In-Vitro Diagnostic Substances Market. Analysis And Forecast to 2020”?
- Get the full picture of the market
- Assess future market prospects
- Identify key success factors affecting the market
- Adjust your marketing strategy
- Ready your business for future trends
3 easy ways to order
- Follow the link below to review a free sample or to buy the report: http://www.indexbox.co.uk/store/us-in-vitro-diagnostic-substances-market-analysis-and-forecast-to-2020/
- Call us +44 20 3239 3063 to discuss your information needs and for special discounts on multi-report orders
- Email your order to firstname.lastname@example.org
Price: 1490 EUR for Single License
TABLE OF CONTENTS
1.1 REPORT DESCRIPTION
1.2 REPORT STRUCTURE
1.3 RESEARCH METHODOLOGY
2. EXECUTIVE SUMMARY
2.1 KEY FINDINGS
2.2 MARKET TRENDS
3. MARKET OVERVIEW
3.1 MARKET VALUE
3.2 TRADE BALANCE
3.3 MARKET OPPORTUNITIES
3.4 MARKET FORECAST TO 2020
4. DOMESTIC PRODUCTION
4.1 PRODUCTION IN 2008-2015
4.2 PRODUCTION BY STATE
4.3 PRODUCER PRICES
5.1 IMPORTS IN 2007-2015
5.2 IMPORTS BY TYPE
5.3 IMPORTS BY COUNTRY
5.4 IMPORT PRICES BY COUNTRY
6.1 EXPORTS IN 2007-2015
6.2 EXPORTS BY TYPE
6.3 EXPORTS BY COUNTRY
6.4 EXPORT PRICES BY COUNTRY
7. COMPETITIVE LANDSCAPE
7.1 INDUSTRY SNAPSHOTS
7.2 INDUSTRY LIFE CYCLE
7.3 BUSINESS LOCATIONS
7.5 ANNUAL PAYROLL
7.6 INDUSTRY PRODUCTIVITY
7.7 ESTABLISHMENT SIZE AND LEGAL FORM
8. COMPANY PROFILES